SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-091445
Filing Date
2020-08-06
Accepted
2020-08-06 16:15:50
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020446-1_10q.htm 10-Q 572657
2 EXHIBIT 31.1 tm2020446d1_ex31-1.htm EX-31.1 8036
3 EXHIBIT 31.2 tm2020446d1_ex31-2.htm EX-31.2 8046
4 EXHIBIT 32.1 tm2020446d1_ex32-1.htm EX-32.1 3845
5 EXHIBIT 32.2 tm2020446d1_ex32-2.htm EX-32.2 4186
  Complete submission text file 0001104659-20-091445.txt   4216146

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT eyeg-20200630.xml EX-101.INS 959410
7 XBRL TAXONOMY EXTENSION SCHEMA eyeg-20200630.xsd EX-101.SCH 39063
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eyeg-20200630_cal.xml EX-101.CAL 38678
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eyeg-20200630_def.xml EX-101.DEF 148948
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyeg-20200630_lab.xml EX-101.LAB 314573
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyeg-20200630_pre.xml EX-101.PRE 279623
Mailing Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452
Business Address 271 WAVERLEY OAKS ROAD SUITE 108 WALTHAM MA 02452 781-788-9043
EYEGATE PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36672 | Film No.: 201081842
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences